J Racial Ethn Health Disparities by Clark, Hollie et al.
HIV-related mortality among adults (≥18 years) of various 
Hispanic or Latino subgroups – United States, 2006–2010
Hollie Clark, MPH1, Aruna Surendera Babu, MPH2, Shericka Harris, MSPH3, and Felicia 
Hardnett, MS1
1Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
2ICF International, Atlanta, Georgia
3Engility, Chantilly, Virginia
Abstract
Hispanics or Latinos residing in the USA are disproportionately affected by HIV when compared 
to whites. Health outcomes for Hispanics or Latinos diagnosed with HIV infection may vary by 
Hispanic or Latino subgroup. We analyzed national mortality data from the National Center for 
Health Statistics for the years 2006 to 2010 to examine differences in HIV-related mortality among 
Hispanics or Latinos by sociodemographic factors and by Hispanic or Latino subgroup. After 
adjusting for age, HIV-related death rates per 100,000 population were highest among Hispanics 
or Latinos who were male (45.6; 95% confidence interval [CI]: 44.4 to 46.9) compared to female 
(12.0; 95% CI: 11.4 to 12.6), or resided in the Northeast (75.1; 95% CI: 72.2 to 77.9) compared to 
other US regions at the time of death. The age-adjusted HIV-related death rate was highest among 
Puerto Ricans (100.9; 95% CI: 97.0 to 104.8) and lowest among Mexicans (16.9; 95% CI: 16.2 to 
17.6). Among all deaths, the proportion of HIV-related deaths was more than 4 times as high 
among Puerto Ricans (adjusted prevalence ratio=4.3; 95% CI: 4.1 to 4.5) compared to Mexicans. 
To ensure better health outcomes for Hispanics or Latinos living with HIV in the USA, medical 
care and treatment programs should be adapted to address the needs of various Hispanic or Latino 
subgroups.
Keywords
HIV; HIV-related mortality; HIV-related deaths; Hispanics; Latinos; Hispanic or Latino subgroups
CORRESPONDING AUTHOR: Hollie Clark, MPH, Epidemiologist, Centers for Disease Control and Prevention, 1600 Clifton Rd. 
NE, MS E47, Atlanta, GA 30333. Overnight mail: 8 Corporate Blvd., Room 2018, Atlanta, GA 30329-1902, phone: 404-639-3983; 
fax: 404-639-2980; HClark@cdc.gov. 
CONFLICTS OF INTEREST
Authors Clark, Babu, Harris, and Hardnett declare that they have no conflicts of interest.
ETHICAL STANDARD STATEMENTS
No animal or human studies were carried out by the authors for this article.
HHS Public Access
Author manuscript
J Racial Ethn Health Disparities. Author manuscript; available in PMC 2017 April 05.
Published in final edited form as:














Hispanics or Latinos in the USA benefit from higher overall life expectancies than certain 
racial/ethnic groups. In 2011, Hispanics or Latinos had a higher life expectancy compared to 
blacks or African Americans (hereafter referred to as blacks) and whites [1]. Both Hispanic 
or Latino females and males also had higher life expectancies (83.1 and 77.9 years, 
respectively) than white females or males (80.5 and 75.6 years, respectively) or black 
females or males (76.3 and 69.3, respectively), and at most ages [1,2]. Life expectancy 
advantages are not however, maintained for Hispanics or Latinos diagnosed with HIV 
infection, who suffer greater morbidity and mortality than whites [3,4]. In 2009, HIV ranked 
17th among the leading causes of death for Hispanics or Latinos, 20th for all persons who 
were not Hispanic or Latino, and 25th for whites [2,5]. During 2010, the estimated death rate 
among Hispanic or Latino adults and adolescents diagnosed with HIV infection was more 
than 2 times the rate for whites [6].
Previous reports involving national HIV surveillance data have substantiated disparities in 
diagnoses of HIV infection between HIV-infected Hispanics or Latinos and whites [7–10]. 
For HIV-infected Hispanics or Latinos living in the USA, disparities exist for diagnoses of 
HIV infection, early diagnosis, and achievement of viral suppression. During 2011, 
Hispanics or Latinos had the second highest rates of newly diagnosed HIV infections (19.5 
per 100,000 population) and stage 3 (AIDS) classifications (16.2), both of which were nearly 
3 times the rates for whites (7.0 and 4.9, respectively) [6,11]. Hispanics or Latinos 
accounted for 21% of persons aged 13 and older in the USA newly diagnosed with HIV 
infection in 2011, despite comprising only 17% of the population [11]. Similar differences 
exist for new HIV infections (HIV incidence) – in 2010, the rate of new HIV infections for 
Hispanics or Latinos (27.5 per 100,000 population) was more than 3 times the rate for 
whites (8.7) [12].
HIV burden for Hispanics or Latinos extends beyond diagnosed infections, as many remain 
undiagnosed and unaware of their HIV infection. Compared to other racial/ethnic groups, 
the estimated prevalence of undiagnosed HIV among Hispanics or Latinos is relatively high. 
At the end of 2008, the prevalence rate for undiagnosed HIV infection among Hispanic or 
Latino males (897.3 per 100,000 population) was 2 times that of white males (419.4), and 
the rate for Hispanic or Latino females (263.1) was 4 times the rate for white females (66.4) 
[7]. Further, Hispanics or Latinos who learn of their HIV infection may be diagnosed at later 
stages [11]. During 2010, among adults and adolescents in 14 national HIV surveillance 
jurisdictions who were newly diagnosed with HIV, 31% of Hispanics or Latinos were 
diagnosed with stage 3 infection (AIDS) as compared to 24% of blacks and 25% of whites 
[13]. Even after engagement in medical care and prescription of antiretroviral therapy, HIV-
infected Hispanics or Latinos may still be less likely to achieve viral suppression than whites 
[10,13,14]. Other research has shown that HIV-infected Hispanics or Latinos with late 
initiation and early discontinuation of antiretroviral therapy have greater losses in years of 
life than other racial/ethnic groups [15].
Geographic region of residence, place of birth, and Hispanic origin are important factors 
contributing to differences in HIV diagnosis rates and HIV-related outcomes for Hispanics 
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or Latinos in the USA. In 2010, Hispanics or Latinos residing in the Northeast had a higher 
HIV diagnosis rate and a higher HIV prevalence than those residing in other regions of the 
USA [16]. Several studies have shown higher percentages of diagnosed HIV infection and/or 
worse health outcomes for Puerto Ricans diagnosed with HIV, which may be influenced by 
the greater likelihood for Puerto Rican-born Hispanics or Latinos to have HIV attributable to 
injection drug use (IDU) than Hispanics or Latinos born elsewhere [6,16,17]. Similar 
disparities have been reported for HIV-related deaths. Results from a 2002 analysis of HIV-
related deaths among Hispanic or Latino subgroups showed Puerto Ricans as having a 
higher rate compared to other Hispanics or Latinos (i.e., Cubans, Mexicans, South/Central 
Americans, and other/unknown subgroups), with Puerto Ricans in the Northeast and 
Midwest regions of the USA having even higher HIV-related death rates than those of non-
Hispanic blacks (18). Additional studies have shown Mexican- or Central American-born 
Hispanics or Latinos diagnosed with HIV to experience better survival than those belonging 
to other subgroups (19).
Higher prevalence rates of undiagnosed HIV infection, higher percentages of late-stage 
diagnoses, and a lesser likelihood of achieving viral suppression could lead to higher HIV-
related death rates for Hispanics or Latinos compared to whites. The goals of this analysis 
were to examine HIV-related death rates and the proportion of HIV-related deaths among all 
deaths that occurred during 2006 to 2010 for Hispanics or Latinos in the USA compared to 
other racial/ethnic groups and to assess whether Hispanic or Latino subgroups or other 
sociodemographic factors (age, sex, birth origin, geographic region of residence) contributed 
to the proportion of HIV-related death among all deaths for Hispanics or Latinos.
METHODS
We analyzed vital statistics data from the National Center for Health Statistics for deaths 
occurring during 2006 to 2010 in adults and adolescents aged 18 and older who resided in 
the USA and for whom Hispanic or Latino ethnic origin had been reported on the death 
certificate [20]. A death was considered HIV related if an HIV-related illness was listed as a 
primary or other (non-primary) cause of death on the death certificate using ICD-10 codes 
[21]. We calculated crude (unadjusted) and age-adjusted HIV-related death rates for blacks, 
Hispanics or Latinos, whites, and other racial/ethnic groups (includes American Indians/
Alaska Natives, Asians, and Native Hawaiians/other Pacific Islanders), and for Hispanics or 
Latinos by age group, sex, Hispanic or Latino subgroup, and US region of residence at the 
time of death. For death data, other Hispanic or Latino subgroup was comprised of deaths 
among persons who identified as Spaniard, Latin American, or other Hispanic or Latino with 
no further geographical specification. For unadjusted rates, we divided the number of HIV-
related deaths for each group by the group population, per 100,000. We calculated 
population denominators using data from the Selected Population Tables of the American 
Community Survey (ACS) for 2006 to 2010 (i.e., 5-year estimates) [22]. The ACS is 
conducted in counties in the United States, has a coverage rate greater than 90% for 
Hispanics or Latinos, and includes estimated population data for Hispanic or Latino 
subgroups (i.e., Cuban, Dominican, Mexican, Puerto Rican, South or Central American, and 
other subgroups [includes persons who identified as Spaniard or other Hispanic or Latino 
with no further geographical specification]). To control for potential confounding due to 
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differences in the age distributions between racial/ethnic groups or between groups of 
Hispanics or Latinos, we calculated age-adjustment weights from the 2010 United States 
Census data for persons aged 18 and older and calculated age-adjusted HIV-related death 
rates using direct standardization to the 2010 United States Census population [23,24]. We 
generated 95% confidence intervals for crude and adjusted HIV-related death rates to allow 
for the comparison of rates [23]. To evaluate differences in HIV-related deaths among all 
deaths for Hispanics or Latinos by age and other socio-demographic factors, we calculated 
the median age at death for both HIV-related and all-cause deaths by Hispanic or Latino 
subgroup, as well as prevalence ratios and adjusted prevalence ratios (controlling for age) by 
age group, sex, Hispanic or Latino subgroup, and US region of residence at the time of 
death. To calculate prevalence ratios, we divided the proportion of HIV-related deaths 
(among all-cause deaths) for the group of interest by the proportion of HIV-related deaths 
(among all-cause deaths) for the reference group. For adjusted prevalence ratios, we 
performed a univariate binomial regression analysis, controlling for age [25]. We calculated 
95% confidence intervals for prevalence ratios and adjusted prevalence ratios to allow for the 
comparison of ratios.
RESULTS
From 2006 to 2010, 58,707 HIV-related deaths were reported for adults and adolescents 
aged 18 and older who were residing in the USA; 7,728 of these deaths (13.2%) were among 
Hispanics or Latinos. Both crude and age-adjusted HIV-related death rates (per 100,000 
population) were highest for blacks (121.2; 95% confidence interval [CI]: 119.9 to 122.5 and 
122.2; 95% CI: 120.9 to 123.6, respectively) followed by Hispanics or Latinos (24.6; 95% 
CI: 24.1 to 25.2 and 28.3; 95% CI: 27.6 to 29.0, respectively), whites (11.5; 95% CI: 11.3 to 
11.7 and 11.2; 95% CI: 11.0 to 11.4, respectively), and persons belonging to other racial/
ethnic groups (6.1; 95% CI: 5.7 to 6.5 and 6.2; 95% CI: 5.8 to 6.6, respectively) (Figure 1). 
Age-adjusted HIV-related death rates for Hispanics or Latinos were more than 2 times the 
rate of whites and nearly 5 times the rate of other racial/ethnic groups. Among Hispanics or 
Latinos, within each corresponding factor, unadjusted HIV-related death rates (per 100,000 
population) were highest for Hispanics or Latinos who were 45–54 years old (53.6; 95% CI: 
51.6 to 55.6), male (38.0; 95% CI: 37.0 to 38.9), Puerto Rican (91.0; 95% CI: 87.5 to 94.4), 
or resided in the Northeast at the time of death (64.4; 95% CI: 62.1 to 66.8) (Table 1). After 
adjusting for age, HIV-related death rates remained highest among Hispanics or Latinos who 
were male (45.6; 95% CI: 44.4 to 46.9), Puerto Rican (100.9; 95% CI: 97.0 to 104.8), or 
resided in the Northeast at the time of death (75.1; 95% CI: 72.2 to 77.9) (Table 1, Figure 2).
Among Hispanics or Latinos, the median age at death was 46 years for those who died of 
HIV-related causes and 71 years for all causes. Among Hispanic or Latino subgroups, the 
median age at HIV-related death ranged from 42 (South/Central Americans) to 52 years 
(Cubans) (Figure 3). Within each corresponding factor, the largest percentage of Hispanics 
or Latinos with HIV-related deaths was among those who were 45–54 years old (35%), male 
(78%), Mexican (37%), and residents of the Northeast region of the USA at the time of 
death (38%) (Tables 1, 2).
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Compared to Hispanics or Latinos who died (decedents) at 45–54 years old, the proportion 
of HIV-related death among all deaths was significantly higher among 35–44 year old 
Hispanic or Latino decedents (prevalence ratio [PR] = 1.5; 95% CI: 1.4 to 1.6) and 
significantly lower for all other age groups (Table 2). After controlling for age, the 
proportion of HIV-related deaths among all deaths was significantly lower among female 
than male Hispanic or Latino decedents (adjusted prevalence ratio [APR] = 0.5; 95% CI: 0.5 
to 0.6) and among Hispanic or Latino decedents who resided in the South (APR = 0.4; 95% 
CI: 0.3 to 0.4), West (APR = 0.2; 95% CI: 0.2 to 0.3), or Midwest (APR 0.2; 95% CI: 0.2 to 
0.3) than in the Northeast. Among all deaths, the proportion of HIV-related deaths was 
significantly higher for all Hispanic or Latino subgroups compared to Mexicans, with Puerto 
Ricans having the highest adjusted prevalence ratio (APR=4.3; 95% CI: 4.1 to 4.5) (Table 1).
DISCUSSION
Our analysis focused specifically on Hispanics or Latinos in the USA with HIV-related 
illness as a cause of death and revealed disparities in HIV-related death for Hispanics or 
Latinos and blacks compared to whites and other racial/ethnic groups. Other studies have 
identified high all-cause death rates or low survival rates for Hispanics or Latinos diagnosed 
with HIV infection compared to whites [6,15,19]. Among Hispanics or Latinos, we 
discovered disparities for both HIV-related death rates and the proportion of HIV-related 
deaths (among all deaths) by age group, sex, Hispanic or Latino subgroup, and region of 
residence. For Hispanic or Latino subgroups, differences in HIV-related death rates and in 
the proportion of HIV-related deaths (among all deaths) were most pronounced between 
Puerto Ricans and Mexicans. By standardizing crude HIV-related death rates to the age 
distribution of the US 2010 population for persons 18 years and older, we were able to make 
comparisons between Hispanics or Latinos and other racial/ethnic groups, and between 
groups of Hispanics or Latinos without the potentially confounding effects of age. Hispanics 
or Latinos included in our population denominator were younger than the standard 
population – 67% of Hispanics or Latinos were 18–44 years old, compared to 49% in the 
standard population [24]. After adjusting for age, the HIV-related death rate for Puerto 
Ricans was approximately 6 times the rate of Mexicans. Also, among all deaths, the 
proportion of HIV-related deaths was 4 times as high among Puerto Ricans as among 
Mexicans. Although our analysis focused primarily on Hispanic or Latino populations, the 
greatest disparity in HIV-related death rates was for blacks, who had approximately 5 times 
the rate of Hispanics or Latinos, 11 times the rate of whites, and 20 times the rate of other 
racial ethnic groups.
Our analysis of HIV-related mortality is consistent with a previous analysis of national 
mortality data from 1996 to 2000, which found Puerto Ricans to have the highest age-
adjusted HIV-related death rate overall, by sex, and by geographic region compared to other 
Hispanic or Latino subgroups [18]. Other studies have shown HIV-positive Hispanics or 
Latinos born in Puerto Rico to have greater risk of HIV-related death or worse survival than 
persons born in the continental USA [19]. Factors contributing to this disparity may include 
risk-taking behaviors or medication adherence issues. For example, for diagnoses of HIV 
infection among adults and adolescents during 2011, the percentages of both males and 
females with HIV attributable to injecting drugs were highest among persons born in Puerto 
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Rico (males, 23%; females, 17%) versus Central America, Cuba, Mexico, or South America 
[6]. This population also had a higher percentage of HIV infection stage 3 (AIDS) diagnoses 
(males, 33%; females, 19%) than persons from other Latin countries [6]. Further, Hispanic 
or Latino men born in Puerto Rico are more likely to have HIV infection attributable to 
injecting drugs compared to Hispanics or Latinos born in other Latin American countries, 
who are more likely to have HIV attributable to sexual contact [6,17,26]. Injecting drugs 
could serve as a barrier to accessing medical care or adhering to antiretroviral therapy, which 
could in turn affect HIV-related morbidity and mortality. We did not assess HIV risk 
behaviors, as national mortality data do not include this information for decedents. 
Additional research is needed to further examine the link between HIV-related mortality and 
HIV risk behaviors for various Hispanic or Latino subgroups and to provide information for 
tailoring programs aimed at improving the continuum of care, especially for Hispanics or 
Latinos who may be injecting drugs or other substances and at higher risk for non-adherence 
to antiretroviral medication and/or medical care [27].
Previous research on mortality among Hispanics or Latinos residing in the USA has 
identified reverse migration – the return of foreign-born Hispanics or Latinos to their 
country of birth after developing a serious illness – as a factor that may contribute to lower 
national death rates for certain Hispanic or Latino subgroups [28]. For example, political 
climate may serve as a barrier to emigration for Cubans, but not necessarily for Mexicans 
[28]. In our analysis, Mexicans had a lower HIV-related death rate and a lower proportion of 
HIV-related deaths (among all-cause deaths) than all other Hispanic or Latino subgroups. 
Reverse migration may have contributed to this outcome, especially for foreign-born 
Mexicans. Puerto Ricans residing in the USA or its dependencies are included in national 
mortality data and are not considered to contribute to the reverse migration effect. However, 
we excluded data from Puerto Rico and other US dependencies due to the unavailability of 
Hispanic or Latino subgroup data or population denominators. During 2011, the 
metropolitan statistical area of San Juan-Caguas-Guaynabo, Puerto Rico had the third 
highest all-cause death rate for adults and adolescents diagnosed with HIV [29]. Additional 
research is needed to examine deaths due to HIV-related illness specifically among 
Hispanics or Latinos residing in Puerto Rico. In addition to migration patterns, 
socioeconomic factors may also play a role in differences in HIV-related deaths among 
Hispanic or Latino subgroups. Cubans residing in the USA have reported higher levels of 
educational attainment and income than other Hispanic or Latino subgroups, and thus may 
benefit from better healthcare access and higher health literacy, which could in turn lead to 
better HIV-related health outcomes [30].
Data from previous studies have shown HIV-infected Hispanics or Latinos in the USA to 
consistently present to care later than whites and with more advanced HIV disease [19]. 
Recently published data on Medicaid enrollees in the southern USA showed Hispanic or 
Latino enrollees as receiving less optimal care and being less likely to receive antiretroviral 
therapy than both blacks and whites [31, 32]. Our analysis did not assess receipt of medical 
care and/or antiretroviral therapy among decedents; however, our results showed higher age-
adjusted rates for death due specifically to HIV-related illnesses for Hispanics or Latinos 
compared to whites, which could be the result of delayed diagnosis of HIV infection and/or 
access to medical care and treatment. Our analysis did not examine acculturation, 
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interactions between place of birth and Hispanic or Latino subgroup, HIV risk behaviors, or 
access to HIV testing and treatment (which could influence the time of diagnosis [i.e., early 
versus delayed] and health outcomes). Further research is needed to examine the factors that 
may contribute to HIV-related death among Hispanics or Latinos.
During 2010, Hispanics or Latinos residing in the Midwestern USA had the lowest HIV 
diagnosis rate (per 100,000 population) (19.2) and the second lowest HIV prevalence rate 
(per 100,000 population) (293.5) compared to other regions [16]. Our analysis revealed 
similar results for HIV-related death among Hispanics or Latinos in the Midwest, who had 
the lowest crude HIV-related death rate (per 100,000 population; 12.4; 95% CI: 11.1 to 13.7) 
and for whom the proportion of HIV-related death among all deaths was significantly lower 
when compared to Hispanics or Latinos residing in the Northeast (APR=0.2; 95% CI: 0.2 to 
0.3). Our results are consistent with previous analyses that have demonstrated similar 
regional differences, with Hispanic or Latino residents of the Northeast having a higher rate 
of HIV-related death and a higher HIV prevalence rate than Hispanic or Latino residents of 
other areas in the USA [16,18]. The higher death rate and prevalence ratio among Hispanics 
or Latinos residing in the Northeast may be explained by Puerto Ricans, who are both more 
likely to reside in the Northeastern region of the USA than in other regions and to have HIV 
attributable to injecting drugs [6,16,33]. Our results are also consistent with the health and 
socioeconomic status of Hispanics or Latinos residing in the Midwest, who have higher 
percentages of health insurance coverage and less poverty than Hispanics or Latinos in the 
USA, overall [34].
There are several limitations associated with this analysis. The number of HIV-related deaths 
for Hispanics or Latinos may be underestimated due to incomplete reporting of Hispanic 
ethnicity on death certificates. In 2008, the ACS changed the layout of the question for 
Hispanic or Latino origin from a grid format to a sequential layout and saw increased 
reporting for Hispanics or Latinos overall, as well as a lower nonresponse rate for the 
Hispanic origin question. Our analysis focused on the years 2006 to 2010; thus, our 
population estimates for Hispanics or Latinos could be slightly underestimated due to the 
data that were collected prior to 2008 using the previous method [35]. For age-adjustment, 
we applied weights derived from the 2010 United States Census, which differs from the time 
period for our study population (2006 to 2010). Any HIV-related deaths in which HIV was 
not mentioned as a cause of death on the death certificate were not captured in this analysis; 
therefore, we may have underestimated HIV-related mortality and the proportion of HIV-
related deaths among all deaths during 2006 to 2010. Finally, despite differences in both 
HIV-related outcomes and socioeconomic status, we were unable to analyze data separately 
for Central Americans and South Americans. South Americans have been shown to have 
better survival following an HIV diagnosis and higher socioeconomic status than Central 
Americans [30,36].
In 2009, Hispanics or Latinos with diagnosed HIV infection were less likely than whites to 
have been prescribed antiretroviral therapy or to have achieved viral suppression [10]. 
Results from our analysis may be used to inform HIV treatment programs for Hispanics or 
Latinos residing in the USA and to target specific Hispanic or Latino subgroups for 
continued access to and engagement and maintenance in HIV-related medical care, with the 
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ultimate goal of reducing HIV-related mortality. The proportion of HIV-related death among 
all deaths was significantly higher among Puerto Ricans than Mexicans. In 2010, Puerto 
Ricans comprised the second largest percentage (9%) of Hispanic or Latino subgroups (i.e., 
Mexicans, Puerto Ricans, Cubans, Dominicans, South Americans, Central Americans, and 
other Hispanics or Latinos) residing in the USA [33]. As Hispanic or Latino populations in 
the USA continue to grow, interventions or programs that focus on engagement and 
maintenance in HIV medical care and/or adherence to antiretroviral therapy must be tailored 
to address the needs of Hispanics or Latinos living with HIV disease. For Puerto Ricans, 
who are more likely than other Hispanic or Latino subgroups to have HIV attributable to 
injecting drugs, such programs may need to incorporate substance abuse counseling and/or 
treatment or harm-reduction approaches [6,16,17,29]. Effective HIV prevention 
interventions for reducing sexual or drug risk behaviors among Hispanics or Latinos have 
addressed gender norms, used non-peers to deliver the intervention, and delivered the 
intervention in a setting other than outreach [37]. These characteristics, along with 
adherence-related barriers such as socioeconomic factors, acculturation, communication 
issues with providers, and fear of deportation (for those without US citizenship or legal 
residence status) should be considered as components of interventions aimed at improving 
the continuum of care for Hispanics or Latinos with HIV attributed to sexual or drug risk 
behaviors [27,31, 32,37–43].
The CDC prioritizes death ascertainment as one of the key activities for jurisdictions that 
collect and report HIV surveillance data. As the completeness of mortality and cause of 
death data continues to improve, more detailed analyses on the factors contributing to racial/
ethnic disparities in HIV-related and other types of deaths for persons diagnosed with HIV in 
the USA will be possible.
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Figure 1. Adjusted HIV-related mortality rate for persons ≥18 years, by race/ethnicity – USA, 
2006–2010
Death rates include deaths with a primary or other cause of death due to HIV infection or 
related conditions, as indicated by ICD 10 codes. Rates are per 100,000 population. 
Population denominators were calculated using the American Community Survey selected 
population tables for 2006–2010. Rates were adjusted for age using weights derived from 
the United States Census 2010 (available at: http://www.census.gov/programs-surveys/
popest.html). "USA" includes persons residing in the USA at the time of death; excludes US 
territories. Hispanics or Latinos can be of any race. Other race/ethnicity includes American 
Indians/Alaska Natives, Asians, and Native Hawaiians/other Pacific Islanders.
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Figure 2. Adjusted HIV-related death rates for Hispanics or Latinos (≥18 years) residing in the 
USA, by Hispanic or Latino subgroup – 2006–2010
Death rates include deaths with a primary or other cause of death due to HIV infection or 
related conditions, as indicated by ICD 10 codes. Rates are per 100,000 population. 
Population denominators were calculated using the American Community Survey selected 
population tables for 2006–2010. Rates were adjusted for age using weights derived from 
the United States Census 2010 (available at: http://www.census.gov/programs-surveys/
popest.html). Hispanics or Latinos can be of any race. "USA" includes persons residing in 
the USA at the time of death; excludes US territories. Other subgroup includes Latin 
Americans (1.7% of all deaths), Spaniards (4.1% of all deaths), and Hispanic or Latino 
subgroups with no geographical specification (94.2% of deaths).
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Figure 3. Median age at death for Hispanics or Latinosa (≥18 years) residing in the USA, by 
Hispanic or Latino subgroup and cause of death – 2006–2010
Hispanics or Latinos can be of any race. "USA" includes persons residing in the USA at the 
time of death; excludes US territories. HIV-related causes includes deaths with a primary or 
other cause of death due to HIV infection or related conditions, as indicated by ICD 10 
codes. Other subgroup includes Latin Americans (1.7% of all deaths), Spaniards (4.1% of all 
deaths), and Hispanic or Latino subgroups with no geographical specification (94.2% of 
deaths).
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Table 1














  18–24 146 (2) 5,841,952 (19) 2.5 (2.1 to 2.9) -
  25–34 840 (11) 8,146,119 (26) 10.3 (9.6 to 11.0) -
  35–44 2,326 (30) 6,979,225 (22) 33.3 (32.0 to 34.7) -
  45–54 2,684 (35) 5,006,191 (16) 53.6 (51.6 to 55.6) -
  55–64 1,203 (16) 2,886,613 (9) 41.7 (39.3 to 44.0) -
  65+ 529 (7) 2,545,502 (8) 20.8 (19.0 to 22.6) -
Sex
  Female 1,678 (22) 15,475,526 (49) 10.8 (10.3 to 11.4) 12.0 (11.4 to 12.6)
  Male 6,050 (78) 15,930,076 (51) 38.0 (37.0 to 38.9) 45.6 (44.4 to 46.9)
Hispanic or Latino
subgroup
  Cuban 474 (6) 1,331,262 (4) 35.6 (32.4 to 38.8) 36.1 (32.9 to 39.4)
  Dominican 151 (2) 931,674 (3) 16.2 (13.6 to 18.8) 19.4 (16.1 to 22.6)
  Mexican 2,874 (37) 19,385,588 (62) 14.8 (14.3 to 15.4) 16.9 (16.2 to 17.6)
  Otherc 672 (9) 1,870,758 (6) 35.9 (33.2 to 38.6) 37.3 (34.5 to 40.2)
  Puerto Rican 2,700 (35) 2,968,356 (9) 91.0 (87.5 to 94.4) 100.9 (97.0 to 104.8)
  South/Central
  American 857 (11) 4,917,964 (16) 17.4 (16.3 to 18.6) 17.9 (16.5 to 19.2)
Region of residenced
  Midwest 338 (4) 2,732,796 (9) 12.4 (11.1 to 13.7) 15.1 (13.4 to 16.9)
  Northeast 2,953 (38) 4,583,744 (15) 64.4 (62.1 to 66.8) 75.1 (72.2 to 77.9)
  South 2,434 (31) 11,380,012 (36) 21.4 (20.5 to 22.2) 23.6 (22.6 to 24.6)
  West 2,003 (26) 12,709,050 (40) 15.8 (15.1 to 16.5) 17.5 (16.7 to 18.3)
Total 7,728 (100) 31,405,602 (100) 24.6 (24.1 to 25.2) 28.3 (27.6 to 29.0)
HIV-related mortality includes deaths with a primary or other cause of death due to HIV infection or related conditions, as indicated by ICD 10 
codes. Hispanics or Latinos can be of any race. ”USA” includes persons residing in the USA at the time of death; excludes US territories. CI 
Confidence interval.
a
Estimated population denominators were obtained from the Selected Population Tables of the American Community Survey for 2006–2010.
b
Rates were adjusted for age using weights that were calculated for persons 18 years and older from the United States Census 2010 data (available 
at: http://www.census.gov/programs-surveys/popest.html).
c
Includes Latin Americans (1.7% of all deaths), Spaniards (4.1% of all deaths), and Hispanic or Latino subgroups with no geographical 
specification (94.2% of all deaths).
d
Region of residence at time of death. Midwest – Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, 
South Dakota, Wisconsin. Northeast – Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, 
Vermont. South – Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North 
Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia. West – Alaska, Arizona, California, Colorado, Hawaii, Idaho, 
Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming.
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Table 2











  18–24 146 (2) 31,925 (5) 0.3 (0.2 to 0.2) -
  25–34 840 (11) 43,049 (7) 0.7 (0.7 to 0.8) -
  35–44 2,326 (30) 72,946 (11) 1.5 (1.4 to 1.6) -
  45–54 2,684 (35) 22,051 (3) Reference -
  55–64 1,203 (16) 91,948 (14) 0.4 (0.3 to 0.4) -
  65+ 529 (7) 388,371 (60) 0.0 (0.0 to 0.0) -
Sex
  Female 1,678 (22) 359,608 (55) 0.3 (0.3 to 0.4) 0.5 (0.5 to 0.6)
  Male 6,050 (78) 290,682 (45) Reference Reference
Hispanic or Latino
subgroup
  Cuban 474 (6) 11,888 (2) 0.9 (0.8 to 1.0) 2.1 (1.9 to 2.3)
  Dominican 151 (2) 361,478 (56) 1.6 (1.4 to 1.9) 1.8 (1.6 to 2.3)
  Mexican 2,874 (37) 66,213 (10) Reference Reference
  Otherc 672 (9) 68,447 (11) 1.2 (1.1 to 1.3) 1.4 (1.3 to 1.5)
  Puerto Rican 2,700 (35) 83,692 (13) 4.1 (3.9 to 4.3) 4.3 (4.1 to 4.5)
  South/Central
  American 857 (11) 58,572 (9) 1.8 (1.7 to 2.0) 1.7 (1.6 to 1.9)
Region of residenced
  Midwest 338 (4) 92,492 (14) 0.3 (0.2 to 0.3) 0.2 (0.2 to 0.3)
  Northeast 2,953 (38) 39,133 (6) Reference Reference
  South 2,434 (31) 255,437 (39) 0.3 (0.3 to 0.3) 0.4 (0.3 to 0.4)
  West 2,003 (26) 263,228 (40) 0.2 (0.2 to 0.3) 0.2 (0.2 to 0.3)
Total 7,728 (100) 650,290 (100) - -
Hispanics or Latinos can be of any race. “USA“ includes persons residing in the USA at the time of death; excludes US territories. CI Confidence 
interval.
a




Includes Latin Americans (1.7% of all deaths), Spaniards (4.1% of all deaths), and Hispanic or Latino subgroups with no geographical 
specification (94.2% of all deaths).
d
Region of residence at time of death. Midwest – Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, 
South Dakota, Wisconsin. Northeast – Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, 
Vermont. South – Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North 
Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia. West – Alaska, Arizona, California, Colorado, Hawaii, Idaho, 
Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming.
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